Compare Danaos Corporation (DAC) vs Medpace Holdings Inc (MEDP) Price & Performance

Danaos Corporation (DAC) trades at $139.81, up 1.08% with bullish technical signals and strong fundamentals. The stock shows robust profitability with a 51.26% net margin and trades at attractive valuations including a P/E of 4.57 and P/B of 0.61. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $7.29 surpassing the $6.80 estimate. The company maintains a record $4.6 billion contracted revenue backlog and pays a $0.90 quarterly dividend.

Outlook remains positive given earnings momentum and undervaluation, though risks include shipping rate volatility and capital expenditure demands. Analyst consensus is evenly split between Buy and Hold ratings, reflecting cautious optimism amid sector cyclicality. The stock's technical strength near key resistance at $138 suggests potential for further gains if fundamentals hold.

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.